Douglas Ward

Chief Executive Officer bei LUMOS DIAGNOSTICS HOLDINGS LIMITED

Vermögen: 18 905 $ am 31.03.2024

Health Technology

Consumer Services

Profil

Douglas Ward is currently the Chief Executive Officer, Director, and Managing Director at Lumos Diagnostics Holdings Ltd.
He previously served as the Chief Executive Officer at Personal Genome Diagnostics, Inc. from 2016 to 2020.
Additionally, he held the position of Vice President of Strategy and Business Development at Hologic, Inc. Mr. Ward completed his undergraduate degree at Ohio Wesleyan University.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
LUMOS DIAGNOSTICS HOLDINGS LTD. 0,10%	18.10.2023	475 000 ( 0,10% )	18 905 $	31.03.2024

Aktive Positionen von Douglas Ward

Unternehmen	Position	Beginn
LUMOS DIAGNOSTICS HOLDINGS LIMITED	Chief Executive Officer	21.06.2022

Alle aktiven Positionen von Douglas Ward

Ehemalige bekannte Positionen von Douglas Ward

Unternehmen	Position	Ende
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Chief Executive Officer	21.04.2020
HOLOGIC, INC.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Douglas Ward im Detail an

Ausbildung von Douglas Ward

Ohio Wesleyan University

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Douglas Ward im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	2
HOLOGIC, INC.	Health Technology
LUMOS DIAGNOSTICS HOLDINGS LIMITED	Health Technology

Private Unternehmen	1
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Health Technology